Canada Healthcare, Regulatory and Reimbursement Landscape - CountryFocus
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Canada Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Canada’s pharmaceutical market value in terms of Canadian dollar was worth $21.8B in 2012, which increased at a CAGR of 4.4% to $27B in 2017. However, the pharmaceutical market value in terms of US dollars was $21.8B in 2012, which decreased at a negative CAGR of 0.9% to $20.8B in 2017. The market value is expected to decrease further to $19.5B by 2024.
The pharmaceutical market value is attributed to growing population, changing demographics, increase in disease conditions, changes in physicians’ prescribing practices, the use of newly launched high-cost medicines, uptake of R&D activities to develop new or improved patented therapies, generics, biologics, and biosimilars. However, the stringent pricing policies and currency fluctuations are the barrier to increasing Canadian pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Merck, Pfizer, and Apotex
- Profiles and SWOT analyses of the major players in the medical device market: GlaxoSmithKline, AstraZeneca, Stryker, EssilorLuxottica, and DePuy Synthes
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Canadian healthcare market
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Canada’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canada’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
- 1 Table of Contents
- 1.1 List of Figures
- 1.2 List of Tables
- 2 Executive Summary
- 2.1 Executive Summary - Overview
- 2.2 Key Highlights
- 2.3 Key Highlights: Healthcare Start-Ups in Canada
- 2.4 Key Events: Canada Healthcare History, 2011-2020
- 2.5 Key Events: Canada Pharmaceutical Market
- 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
- 2.7 Key Events: Mergers and Acquisitions
- 2.8 Country Profile, Canada, 2019
- 3 Overview of Pharmaceutical Market
- 3.1 Pharmaceutical Market - Overview
- 3.2 Pharmaceutical Market - Exports
- 3.3 Pharmaceutical Market - Imports
- 3.4 Pharmaceutical Market - Supply Channels, Canada
- 3.5 Pharmaceutical Market - Market Segments
- 3.6 COVID-19 Epidemiology, Canada
- 3.7 Government Response to Mitigate COVID-19
- 3.8 COVID-19 Impact and Developments in Healthcare Market, Canada
- 3.9 COVID-19 IVD Market
- 3.10 Pharmaceutical Market - Major Players
- 4 Overview of Medical Devices Market
- 4.1 Medical Device Market - Overview
- 4.2 Medical Device Market - Major Segments
- 4.3 Medical Device Market - Major Players
- 5 Pharmaceutical and Medical Device Market - Drivers and Barriers
- 5.1 Drivers
- 5.2 Barriers
- 6 Deal analysis
- 6.1 Deal Analysis: M&A, VC, and PE Deals, Pharmaceutical Market, Canada 2019-2020
- 6.2 Deal Analysis: M&A, VC, and PE Deals, Medical Device Market, Canada 2019-2020
- 7 HealthTech Landscape
- 7.1 HealthTech Landscape
- 7.1.1 HealthTech Deals Landscape, Canada
- 7.2 Key HealthTech Deals, Canada
- 7.3 Adoption of Technology in Healthcare, Canada
- 7.4 Key Developments: Technology in Healthcare, Canada
- 7.5 HealthTech Landscape- Canada- Benefits and Risks
- 8 Market Access
- 8.1 Overview of Healthcare System, Canada
- 8.2 Reimbursement of Medicinal Products, Canada
- 8.3 Reimbursement of Medical Devices, Canada
- 8.4 Overview of Public Insurance Providers, Canada
- 8.5 Overview of Private Insurance Providers, Canada
- 8.6 Healthcare Spending and Health Price Index, Canada
- 8.7 Pricing Policies, Canada
- 8.8 Regulatory Landscape, Canada
- 8.8.1 Market Authorization for Pharmaceutical Drugs, Canada
- 8.8.2 Market Authorization for Medical Devices, Canada
- 8.8.3 Drug Establishment Licence Regulation, Canada
- 8.8.4 Medical Device Establishment Licence Regulation, Canada
- 8.8.5 Intellectual Property Rights, Patent, Canada
- 8.8.6 Intellectual Property Rights, Trademark, Canada
- 8.8.7 Pharmaceutical Clinical Trials Landscape, Canada
- 8.8.9 Medical Devices Clinical Trials Landscape, Canada
- 8.8.10 COVID-19 Clinical Trials, Canada
- 8.8.11 Clinical Trial Regulations, Canada
- 8.8.12 Pharmaceutical Advertising Regulations, Canada
- 8.8.13 Labeling and Packaging Regulations, Canada
- 9 Country Healthcare Landscape
- 9.1 Canada Healthcare Policy Highlights
- 9.2 Healthcare Facilities, Canada
- 9.3 Healthcare Parameters, Canada
- 9.4 Life Expectancy and Immunization Rate, Canada
- 9.5 Environmental Health, Canada
- 9.6 Healthcare Personnel, Canada
- 9.7 Disease Burden, Canada
- 9.8 Healthcare Expenditure
- 10 Trade Associations, Canada
- 11 Trade Fairs, Canada
- 12 Opportunities and Challenges
- 13 Appendix
- 13.1 Research Methodology
- 13.1.1 Coverage
- 13.1.2 Secondary Research
- 13.1.3 Forecasts
- 13.1.4 Expert Panel
- 13.2 Bibliography
- 13.3 Contact Us
- 13.4 Disclaimer
- List of Tables
- Table 1: Major Therapeutic Areas by Sales of Patented Drug Products, Canada, 2017
- Table 2: COVID-19 Indicators (Number of cases), Global and Canada, 2020
- Table 3: COVID-19 Nucleic Acid Amplification Tests (NAATs), Canada, 2020
- Table 4: COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA), Canada, 2020
- Table 5: COVID-19 Point-of-Care (POC) Tests, Canada, 2020
- Table 6: Polymerase Chain Reaction (PCR) Systems, Canada, 2020
- Table 7: COVID-19 Other Equipment, Canada, 2020
- Table 8: Medical Devices Market, Major Segments ($B), Canada, 2019
- Table 9: Orthopedic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 10: Ophthalmic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 11: Healthcare IT Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 12: Drug Delivery Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 13: General Surgery Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 14: List of Provincial Insurance Programs, Canada
- Table 15: Fees for Examination of Drug Submission, Canada, 2020
- Table 16: Fees for Right to Sell Drugs, Canada, 2020
- Table 17: Fees for Examination of Medical Devices Licence Application, Canada, 2020
- Table 18: Fees for Right to Sell Medical Devices, Canada, 2020
- Table 19: Fees for Examination of Drug Establishment Licence, Canada, 2020
- Table 20: Patent Fees, Canada, 2020
- Table 21: Trademark Fees, Canada, 2020
- Table 22: PAAB Advertisement Fees, Canada
- Table 23: Label of a Pharmaceutical Main Panel, Canada
- Table 24: Label of a Pharmaceutical Any Other Panel, Canada
- Table 25: General Labeling of Medical Devices, Canada
- Table 26: Outer Container Label of IVD Devices, Canada
- Table 27: Immediate Container Label of IVD Devices, Canada
- List of Figures
- Figure 1: Pharmaceutical Market, Canada, Revenue ($B), 2012-2019
- Figure 2: Medical Devices Market, Canada, Revenue ($B), 2015-2020
- Figure 3: Healthcare Startups in Canada, 2020
- Figure 4: Number of Deals (2019-2020)
- Figure 5: 2019-2020 Deal Overview by Region
- Figure 6: Country Profile, Canada, 2019
- Figure 7: Pharmaceutical Market, Canada, Revenue ($B), 2012-2019
- Figure 8: Pharmaceutical Market, Canada, Revenue Forecast ($B), 2020-2024
- Figure 9: Pharmaceutical Exports ($B), Canada, 2012-2019
- Figure 10: Top Export Partners, Canada, 2019
- Figure 11: Pharmaceutical Imports ($B), Canada, 2012-2019
- Figure 12: Top Import Partners, Canada, 2019
- Figure 13: Pharmaceutical Market, Supply Channel, Canada, 2017
- Figure 14: Generics Market, Canada, Revenue ($B), 2012-2018
- Figure 15: Generic Drugs - Patented Drugs Share by Value, Canada, 2012-2018
- Figure 16: Health Canada Approved Biologics, Canada, 2020
- Figure 17: Health Canada Approved Biosimilars, Canada, 2020
- Figure 18: OTC Market, Canada, Revenue ($B), 2012-2018
- Figure 19: OTC Market by Drug Category, Canada, Revenue ($M), 2018
- Figure 20: Major Therapeutic Areas by Sales of Patented Drug Products, Canada, 2017
- Figure 21: COVID-19 (Number of cases), Canada, 2020
- Figure 22: COVID-19 (Number of deaths), Canada, 2020
- Figure 23: Medical Devices Market, Canada, Revenue ($B), 2015-2020
- Figure 24: Medical Devices Market, Canada, Revenue Forecast ($B), 2021-2025
- Figure 25: Medical Devices Market, Major Segments (%), Canada, 2019
- Figure 26: Orthopedic Devices Market, Canada, Revenue ($B), 2015-2022
- Figure 27: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2019
- Figure 28: Ophthalmic Devices Market, Canada, Revenue ($B), 2015-2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook